封面
市场调查报告书
商品编码
1683443

聚合物辅料:市场占有率分析、产业趋势与统计、成长预测(2025-2030 年)

Polymer Excipients - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计预测期内聚合物辅料市场复合年增长率将超过 6%。

聚合物辅料-市场-IMG1

主要亮点

  • 随着全球生物製药趋势的成长,预计市场将面临各种成长机会。
  • 根据产品类型,聚乙烯吡咯烷酮(聚维酮)预计将占据市场主导地位,因为其多功能性导致需求不断增加。
  • 欧洲地区在全球聚合物辅料市场占据主导地位,其中消费量最高的国家为德国、英国和法国。

聚合物辅料市场趋势

聚乙烯吡咯烷酮(聚维酮)的需求不断增加

  • 聚合物辅料是与活性药物成分一起配製的物质。它们由天然存在的聚合物化合物(例如明胶)、半合成化合物(例如纤维素衍生物)和合成化合物(例如聚乙二醇)组成。
  • 聚乙烯吡咯烷酮具有独特的易被人体吸收的特性,因此,预计预测期内製药业对聚乙烯吡咯烷酮的需求增加将推动聚合物辅料市场的发展。
  • 此外聚乙烯吡咯烷酮还具有溶解性高、成膜性优良、生理不渗透性等优良性能。由于这些特性,它被广泛用于锭剂、胶囊、口服液、灭菌剂和注射剂的生产。预计这些因素将在预测期内推动需求,刺激聚合物辅料市场。
  • 预测期内,全球聚乙烯吡咯烷酮(聚维酮)市场预计将以超过 8% 的复合年增长率成长。预计这将对预测期内聚合物辅料市场的成长产生正面影响。
  • 由于上述因素,预计预测期内聚合物辅料市场将快速成长。

欧洲主导市场

  • 预计预测期内欧洲将主导聚合物辅料市场。由于製药业的不断发展和人口老化,英国、德国和法国等国家对聚合物辅料的需求正在增加,此外,粘合剂、被覆剂、调味剂、防腐剂和甜味剂等各种应用的需求也在增加。
  • 口服固态剂型(OSDF)中辅料的使用不断增加、研发不断增加以及医疗保健基础设施不断改善,正在推动该地区药品中聚合物辅料的消费。
  • 此外,聚合物赋形剂被用作治疗药物中活性成分的粘合剂,以促进其吸收。聚合物辅料是惰性剂,对药物不起任何治疗效果。它还有助于维持治疗药物的剂量、平衡和有效传递。这些因素增加了对聚合物赋形剂的需求,预计将在预测期内推动市场发展。
  • 预计预测期内欧洲医药市场将以超过 4% 的复合年增长率成长,到 2027 年市场价值将达到 2,200 亿美元。这很可能为预测期内的聚合物辅料市场提供有利的机会。
  • 在欧洲地区企业发展的主要企业包括BASF公司、陶氏化学公司和赢创工业集团。
  • 上述因素加上政府的支持,将导致预测期内对聚合物辅料的需求增加。

聚合物辅料产业概况

聚合物辅料市场较为分散,主要企业仅占有少量份额。市场的主要企业包括嘉吉公司、陶氏化学、赢创工业股份公司、ABITEC 和BASFSE。

其他福利:

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

目录

第 1 章 简介

  • 调查前提条件
  • 研究范围

第二章调查方法

第三章执行摘要

第四章 市场动态

  • 驱动程式
    • 製药业的成长
    • 涂层应用对聚合物辅料的需求不断增加
  • 限制因素
    • 监管机构的严格监管
    • 对所需产品品质的担忧
  • 产业价值链分析
  • 波特五力分析
    • 供应商的议价能力
    • 消费者议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争程度

第五章 市场区隔

  • 产品类型
    • 聚乙烯吡咯烷酮
    • 聚乙二醇
    • 淀粉
    • 结晶纤维素(MCC)
    • 乙基纤维素和甲基纤维素
    • 羟丙基甲基纤维素 (HPMC)
    • 其他的
  • 应用
    • 粘合剂
    • 黏度调节剂
    • 被覆剂
    • 香水
    • 防腐剂
    • 色素
    • 甜味剂
    • 其他的
  • 地区
    • 亚太地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 其他亚太地区
    • 北美洲
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 义大利
      • 法国
      • 其他欧洲国家
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地区
    • 中东和非洲
      • 沙乌地阿拉伯
      • 南非
      • 其他中东和非洲地区

第六章 竞争格局

  • 併购、合资、合作与协议
  • 市场占有率(%)/排名分析
  • 主要企业策略
  • 公司简介
    • ABITEC
    • ADM
    • Ashland
    • BASF SE
    • Cargill, Incorporated.
    • Colorcon
    • Croda International Plc
    • DFE Pharma
    • Dow
    • DuPont
    • Eastman Chemical Company
    • Evonik Industries AG
    • FINAR LIMITED
    • JRS PHARMA
    • Kerry Inc.
    • Roquette Freres
    • The Lubrizol Corporation

第七章 市场机会与未来趋势

  • 全球生物製药的扩张趋势
  • 其他机会
简介目录
Product Code: 70898

The Polymer Excipients Market is expected to register a CAGR of greater than 6% during the forecast period.

Polymer Excipients - Market - IMG1

Key Highlights

  • Rising trend for biopharmaceuticals across the globe is expected to offer various lucrative opportunities for the growth of market.
  • By product type, polyvinylpyrrolidone (povidone) segment is expected to dominate the market owing to the increase in the demand due to its multifunctional abilities.
  • Europe region dominated the polymer excipients market across the globe with the largest consumption from countries such as Germany, United Kingdom, and France.

Polymer Excipients Market Trends

Increasing Demand for Polyvinylpyrrolidone (Povidone)

  • Polymer excipients are the substances which are formulated alongside the active ingredient of a medication. They consist of macromolecular compounds of natural origin such as gelatin, semisynthetic compounds such as cellulose derivatives, and synthetic compounds such as polyethylene glycols.
  • The increasing demand of polyvinylpyrrolidone in the pharmaceutical industry owing to its unique ability to get readily absorbed in the body is expected to propel the polymer excipients market during the forecast period.
  • Additionally, polyvinylpyrrolidone has superior properties such as good solubility, superb film forming, and physiological impermissibility. Owing to these properties, it is widely used in manufacturing tablets, capsules, oral liquids, sterilization disinfectant, and injection. Due to these factors, its demand is expected to increase during the forecast period, which would stimulate the polymer excipients market.
  • The global polyvinylpyrrolidone (povidone) market is expected to grow at a CAGR of over 8% during the forecast period. This is anticipated to positively impact the growth of polymer excipients market during the forecast period.
  • Owing to all the above-mentioned factors for polymer excipients, its market is expected to grow rapidly over the forecast period.

Europe Region to Dominate the Market

  • Europe region is expected to dominate the market for polymer excipients during the forecast period. In countries like United Kingdom, Germany, and France, owing to increasing demand from various applications such as binders, coating agents, flavors, preservatives, and sweeteners coupled with growing pharmaceutical industry in the region and growing old age population, the demand for polymer excipients has been increasing in the region.
  • The increased utilization of excipients in oral solid dosage form (OSDF) along with increased R&D and improved medical infrastructure has led to an increased consumption of polymer excipients in pharmaceutical drugs in the region.
  • Additionally, polymer excipients are used as binders for active ingredients in therapeutic drugs so that the active ingredients can be absorbed easily. They are inactive agents and do not have any therapeutic effect on the medicine. Also, they help in maintaining the dosage, balance and efficient delivery of the therapeutic drug. Due to these factors, the demand of polymer excipients is increasing, which expected to stimulate its market during the forecast period.
  • The Europe pharmaceuticals drugs market is expected to grow at a CAGR of over 4% during the forecast period and is expected to reach a market value of USD 220 billion by 2027. This is likely to provide lucrative opportunities for the polymer excipients market during the forecast period.
  • Some of the major companies operating in Europe region are - BASF SE, Dow, and Evonik Industries AG.
  • The aforementioned factors, coupled with government support, are contributing to the increasing demand forpolymer excipients during the forecast period.

Polymer Excipients Industry Overview

The Polymer Excipients market is fragmented with top players accounting for a marginal share of the market. Some of the key companies in the market include Cargill, Incorporated, Dow, Evonik Industries AG, ABITEC, and BASF SE.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Drivers
    • 4.1.1 Growing Pharmaceutical Industry
    • 4.1.2 Rising Demand for Polymer Excipients from Coatings Application
  • 4.2 Restraints
    • 4.2.1 Stringent Rules by Regulatory Bodies
    • 4.2.2 Concerns to Meet the Required Quality of Product
  • 4.3 Industry Value Chain Analysis
  • 4.4 Porters Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Degree of Competition

5 MARKET SEGMENTATION

  • 5.1 Product Type
    • 5.1.1 Polyvinylpyrrolidone
    • 5.1.2 Polyethylene Glycol
    • 5.1.3 Starch
    • 5.1.4 Micro Crystalline Cellulose (MCC)
    • 5.1.5 Ethyl and Methyl Cellulose
    • 5.1.6 Hydroxypropyl Methylcellulose (HPMC)
    • 5.1.7 Others
  • 5.2 Application
    • 5.2.1 Binders
    • 5.2.2 Viscosity Modifiers
    • 5.2.3 Coatings
    • 5.2.4 Flavors
    • 5.2.5 Preservatives
    • 5.2.6 Colorants
    • 5.2.7 Sweeteners
    • 5.2.8 Others
  • 5.3 Geography
    • 5.3.1 Asia-Pacific
      • 5.3.1.1 China
      • 5.3.1.2 India
      • 5.3.1.3 Japan
      • 5.3.1.4 South Korea
      • 5.3.1.5 Rest of Asia-Pacific
    • 5.3.2 North America
      • 5.3.2.1 United States
      • 5.3.2.2 Canada
      • 5.3.2.3 Mexico
    • 5.3.3 Europe
      • 5.3.3.1 Germany
      • 5.3.3.2 United Kingdom
      • 5.3.3.3 Italy
      • 5.3.3.4 France
      • 5.3.3.5 Rest of Europe
    • 5.3.4 South America
      • 5.3.4.1 Brazil
      • 5.3.4.2 Argentina
      • 5.3.4.3 Rest of South America
    • 5.3.5 Middle-East and Africa
      • 5.3.5.1 Saudi Arabia
      • 5.3.5.2 South Africa
      • 5.3.5.3 Rest of Middle-East and Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
  • 6.2 Market Share (%)/Ranking Analysis
  • 6.3 Strategies Adopted by Leading Players
  • 6.4 Company Profiles
    • 6.4.1 ABITEC
    • 6.4.2 ADM
    • 6.4.3 Ashland
    • 6.4.4 BASF SE
    • 6.4.5 Cargill, Incorporated.
    • 6.4.6 Colorcon
    • 6.4.7 Croda International Plc
    • 6.4.8 DFE Pharma
    • 6.4.9 Dow
    • 6.4.10 DuPont
    • 6.4.11 Eastman Chemical Company
    • 6.4.12 Evonik Industries AG
    • 6.4.13 FINAR LIMITED
    • 6.4.14 JRS PHARMA
    • 6.4.15 Kerry Inc.
    • 6.4.16 Roquette Freres
    • 6.4.17 The Lubrizol Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

  • 7.1 Growing Trend of Biopharmaceuticals Across the Globe
  • 7.2 Other Opportunities